Category: Protocols

  • Amble Health Expands Access to Compounded Peptides via Telehealth Platform

    Amble Health has announced the launch of six compounded peptide options available through its online medical care platform, marking another step forward in making peptide-based care more accessible to patients across the country. By integrating these offerings into a telehealth model, the company is helping to streamline the process of connecting individuals with licensed medical professionals who can evaluate whether compounded peptide therapies may be appropriate for their individual health goals.

    The move reflects a broader trend in healthcare where telemedicine platforms are expanding their offerings to include more specialized and personalized treatment options. Compounded peptides have drawn significant interest in recent years for their potential role in supporting various aspects of wellness, and online medical care models like Amble Health’s can reduce barriers such as travel time, scheduling conflicts, and limited local availability of specialists familiar with peptide protocols.

    One of the key benefits of this kind of platform is the emphasis on physician oversight. Rather than patients sourcing peptides independently, Amble Health’s model routes interested individuals through a structured medical intake and consultation process, which can help ensure that any decisions about compounded peptide use are made in consultation with a qualified provider. This kind of guided access model is increasingly seen as a responsible way to bring emerging therapies to a wider population while maintaining appropriate clinical checkpoints.

    Expanding telehealth access to six distinct compounded peptide options also gives patients and their physicians more flexibility to discuss which formulation might align best with a person’s specific wellness objectives. As interest in peptide-based approaches continues to grow among both patients and practitioners, platforms that combine convenience with medical supervision may help more people explore these options in a thoughtful, physician-guided manner.

    As the compounded peptide space continues to evolve, developments like this highlight the ongoing effort by healthcare companies to modernize access while keeping licensed medical guidance at the center of the process. This article is for informational purposes only and is not intended as medical advice.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Amble Health Launches Six Compounded Peptide Options Through Online Medical Care – Eastern Progress

  • The Rise of Clinician-Guided Peptide Care: A Safer Path Forward

    A notable shift is taking place in the world of peptide therapeutics: a move toward clinician-guided care models that prioritize medical supervision, individualized protocols, and professional oversight. This trend reflects a broader maturation of the peptide wellness space, as more practitioners and patients recognize the value of working within structured, medically informed frameworks.

    Clinician-guided peptide care typically involves working with licensed healthcare providers who can assess a patient’s health history, order appropriate labs, and tailor peptide protocols to individual needs. This approach stands in contrast to unsupervised or self-directed use, and it offers several potential advantages: more accurate dosing, better monitoring for how an individual responds over time, and the ability to adjust course if needed based on professional clinical judgment.

    This trend is encouraging for several reasons. First, it signals growing legitimacy and professionalization within the peptide space, as more clinics and healthcare providers integrate peptide therapies into comprehensive wellness and longevity programs. Second, it places patient safety and informed decision-making at the center of the conversation, which benefits both the field’s reputation and the people seeking these therapies. Third, clinician involvement often means better education for patients about what to expect, how peptides may work, and what realistic outcomes look like.

    For the broader peptide community, this movement toward professional guidance could help build trust with regulators, medical institutions, and the public. As peptide therapies continue to attract interest for various wellness and recovery applications, having a framework rooted in clinical expertise may support more consistent, thoughtful, and responsible use. It also opens the door for better data collection, as clinicians tracking patient outcomes can contribute to a growing body of real-world experience that may eventually inform more formal research.

    At True North Labs, we view this emphasis on clinician-guided care as a positive step for the peptide field overall. It represents a thoughtful balance between innovation and responsibility, helping ensure that interest in peptide therapies is matched by appropriate medical context and support.

    This article is for informational purposes only and is not medical advice. Please consult a qualified healthcare provider before considering any peptide-based therapy.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Clinician-Guided Peptide Care – Trend Hunter

  • Physician-Led Peptide and GLP-1 Telehealth Care Now Available Nationwide

    Access to physician-guided peptide and GLP-1 therapies is expanding, as family-run Protocol Health rolls out its telehealth platform, Protocol MD, to patients across all 50 states. The move brings structured, medically supervised care to a wider population seeking support for weight management and other peptide-related wellness goals.

    One of the more encouraging aspects of this expansion is the emphasis on physician oversight. Rather than offering peptides or GLP-1 medications without medical guidance, Protocol MD connects patients with licensed physicians who can help evaluate individual health needs. The platform also offers online bloodwork services, allowing patients to track relevant health markers as part of their care journey, which can support more informed, personalized treatment decisions.

    This kind of nationwide telehealth model reflects a broader trend in the peptide and metabolic health space: making physician-led care more accessible, especially for people in areas without easy access to specialists in this growing field. By combining remote consultations, lab testing, and ongoing physician involvement, companies like Protocol Health are working to ensure that interest in GLP-1 and peptide therapies is matched with appropriate clinical structure rather than unsupervised self-administration.

    For patients, this type of expansion can mean greater convenience without sacrificing medical supervision—an important balance as demand for peptide-based therapies continues to rise nationally. Family-run companies entering this space with a clinical, physician-first approach may also help set a standard for responsible telehealth delivery in the peptide industry.

    As more platforms like Protocol MD become available, patients interested in GLP-1 or peptide therapies may find it easier to access qualified medical guidance alongside these treatments. As always, anyone considering a new therapy should consult directly with a licensed healthcare provider to determine what is appropriate for their individual situation. This article is for informational purposes only and is not medical advice.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Family-Run Protocol Health Brings Its Physician-Led Care Nationwide Through Protocol MD, Offering GLP-1, Peptide Therapy and Bloodwork Online in All 50 States – USA Today

  • Physician-Led Peptide and GLP-1 Care Now Available Nationwide Through New Telehealth Platform

    Physician-Led Peptide and GLP-1 Care Now Available Nationwide Through New Telehealth Platform

    A family-run healthcare company, Protocol Health, has expanded its physician-led services nationwide through a new telehealth platform called Protocol MD. The service connects patients across all 50 states with licensed physicians who oversee personalized care plans that include GLP-1 weight loss treatment, peptide therapy, and at-home bloodwork testing.

    This expansion reflects a broader trend of making medically supervised peptide and metabolic therapies more accessible to people who may not have easy access to specialized clinics in their area. By combining telehealth consultations with lab testing services, the platform aims to give patients a more complete picture of their health before and during treatment, while keeping a physician involved throughout the process.

    Peptide therapies and GLP-1 medications have drawn significant interest in recent years for their roles in weight management and metabolic health support. Offering these treatments through a structured, physician-led model—rather than unsupervised or informal channels—can help ensure that patients receive appropriate monitoring, dosing guidance, and follow-up care, which are all important components of responsible treatment.

    The move toward nationwide telehealth access also highlights how digital health platforms are helping bridge gaps between patients and qualified medical providers, particularly in rural or underserved regions where specialized weight-loss and hormone-related care may otherwise be difficult to find. By integrating bloodwork directly into the care pathway, patients can also track relevant biomarkers over time, which may support more informed conversations with their physicians about treatment progress.

    As telehealth continues to evolve, services like Protocol MD represent part of a growing effort within the healthcare industry to combine convenience with clinical oversight, aiming to make emerging treatments like peptide therapy more structured and medically guided. This is for informational purposes only and not medical advice.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Family-Run Protocol Health Brings Its Physician-Led Care Nationwide Through Protocol MD, Offering GLP-1 Weight Loss, Peptide Therapy and Bloodwork Online in All 50 States – The Manila Times

  • New Clinical Framework Supports Safely Reducing Insulin Use with GLP-1 Therapy in Type 2 Diabetes

    New Clinical Framework Supports Safely Reducing Insulin Use with GLP-1 Therapy in Type 2 Diabetes

    A new publication in the peer-reviewed journal Cureus offers encouraging news for people managing type 2 diabetes: a practical, evidence-based framework for reducing insulin use in patients who are also taking GLP-1 (glucagon-like peptide-1) receptor agonist medications. This development reflects a broader and welcome shift in diabetes care toward simplifying treatment regimens when appropriate, without compromising blood sugar control.

    GLP-1-based therapies have already transformed the diabetes treatment landscape by helping patients improve glycemic control, often while supporting weight management. For many patients on combination therapy with insulin, this raises an important clinical question: once GLP-1 therapy is established and working well, can insulin doses be safely reduced or even discontinued? The new framework synthesizes existing evidence to help clinicians answer this question with greater confidence and consistency.

    The significance of this work lies in its practical, patient-centered approach. Insulin therapy, while effective, carries burdens for patients including the risk of low blood sugar episodes, weight gain, and the day-to-day complexity of injections and dose adjustments. By offering clinicians clear criteria and a structured process for considering insulin deintensification, this framework could help more patients transition toward simpler, more manageable treatment plans when their clinical picture supports it.

    This kind of synthesis work is valuable because it translates scattered research findings into an actionable tool that healthcare providers can use in everyday practice. Rather than leaving decisions about combining or adjusting GLP-1 and insulin therapies to guesswork, clinicians now have a reference point grounded in available evidence. For patients, this could mean more personalized care that takes into account their individual response to GLP-1 therapy and their broader treatment goals.

    As GLP-1 medications continue to expand in availability and use, frameworks like this one help ensure that the full potential of these therapies is realized safely and effectively. Streamlining diabetes regimens where clinically appropriate can reduce treatment burden and support better long-term adherence and outcomes. This article is for informational purposes only and is not medical advice.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Insulin Deintensification After Glucagon-Like Peptide-1 (GLP-1)-Based Therapy in Type 2 Diabetes: Evidence and a Practical Clinical Framework – Cureus

  • Educators Spotlight Peptide Therapy’s Growing Role in Podiatric Care

    Educators Spotlight Peptide Therapy’s Growing Role in Podiatric Care

    Peptide therapy continues to expand its footprint across medical specialties, and the latest example comes from the world of podiatry. HMP Global Learning Network, a respected platform for continuing medical education, has published an educational overview aimed at helping podiatrists understand how peptide-based approaches may be relevant to lower extremity health.

    The resource highlights the expanding interest among foot and ankle specialists in exploring peptides as part of a broader toolkit for supporting tissue health, recovery, and overall patient care. As peptide science matures, more clinical fields are taking a closer look at how these naturally occurring and synthetic compounds might complement existing treatment approaches for conditions affecting the lower extremities.

    This kind of educational outreach is an encouraging sign for the peptide field as a whole. When established medical education platforms like HMP Global Learning Network dedicate resources to informing specialists about peptide therapy, it reflects a maturing area of interest that is increasingly entering mainstream clinical conversations. Podiatrists, who regularly manage wound care, soft tissue injuries, and recovery from foot and ankle procedures, represent a specialty where interest in regenerative and supportive therapies continues to grow.

    Greater awareness and education among practitioners is a positive step toward ensuring that any emerging therapies are discussed thoughtfully and responsibly within specialized care settings. As more clinicians across different specialties become familiar with the fundamentals of peptide science, it may pave the way for more informed, specialty-specific research and clinical discussions in the future.

    This article is for informational purposes only and is not intended as medical advice. Patients and clinicians should consult qualified healthcare professionals for guidance specific to individual medical needs.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Peptide Therapy and the Lower Extremity: What Every Podiatrist Should Know – HMP Global Learning Network

  • Understanding Peptide Therapy: A Guide to FDA-Approved Options and Their Benefits

    Peptide therapy continues to gain attention as more people look for science-backed ways to support their health, and a recent overview from Haute Living helps clarify what’s currently available and FDA-approved in this growing field. As interest in peptides expands, having clear, organized information about their uses and regulatory status is a welcome resource for anyone curious about these compounds.

    Peptides are short chains of amino acids that occur naturally in the body and play roles in everything from hormone regulation to tissue repair. Because of this versatility, researchers and clinicians have developed peptide-based treatments for a range of purposes, including some that have successfully navigated the FDA approval process. These approved options represent years of clinical testing and regulatory review, giving patients and providers confidence in their safety and efficacy profiles when used appropriately.

    The variety of peptide types available today reflects how far this area of medicine has come. From peptides designed to support metabolic health to those studied for their potential role in recovery and healing, the diversity of applications shows the broad promise this class of molecules holds. Having FDA-approved options in the mix is particularly encouraging, as it means these particular peptides have met rigorous standards for manufacturing quality, dosing consistency, and clinical outcomes.

    For consumers and healthcare providers alike, resources that distinguish between FDA-approved peptide therapies and other formulations are valuable tools for making informed decisions. This kind of clarity helps ensure that people interested in exploring peptide therapy can have more productive conversations with their healthcare providers about which options might align with their individual health goals and circumstances.

    As research into peptides continues to expand, it’s likely that more applications will move through the regulatory pipeline, potentially bringing additional approved options to patients in the future. The growing body of knowledge around peptide therapy—paired with regulatory oversight—suggests a maturing field that balances innovation with patient safety.

    This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new treatment or therapy.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Peptide Therapy: Uses, Types & What’s FDA-Approved – Haute Living

  • Understanding Peptides: How They’re Shaping Medicine, Skincare, and Wellness

    Peptides have moved from a niche topic in biochemistry labs to a familiar term in medicine cabinets and skincare aisles alike. These short chains of amino acids, which serve as the building blocks of proteins, are increasingly recognized for their diverse and beneficial roles in the body—from supporting tissue repair to regulating hormones and immune responses.

    In medicine, peptide-based therapies have already made a meaningful impact. Several peptide drugs are FDA-approved and used to manage conditions such as diabetes, osteoporosis, and certain hormonal imbalances. Their ability to mimic naturally occurring biological signals allows them to interact with the body in targeted ways, often with fewer off-target effects compared to broader-acting drugs. This precision is part of why researchers and clinicians continue to explore new therapeutic applications for peptides across a range of health conditions.

    Beyond prescription medicine, peptides have also become a staple ingredient in skincare formulations. Topical peptides are frequently included in serums and creams aimed at supporting collagen production and improving skin texture. While results can vary by individual and formulation, the growing consumer interest reflects broader recognition of peptides’ potential to support skin health as part of a well-rounded skincare routine.

    In the wellness space, interest in peptides has expanded to include areas like recovery, sleep support, and general vitality. This growing curiosity has helped drive further scientific interest, encouraging more research into how different peptides function and how they might be used safely and effectively. As understanding deepens, this ongoing research helps separate well-supported uses from areas still needing more investigation.

    Overall, the expanding presence of peptides across medicine, skincare, and wellness highlights their versatility and the promise they hold for future innovation. As research continues, consumers and patients alike may benefit from clearer guidance on how peptides can be safely incorporated into health and beauty routines. This article is for informational purposes only and is not intended as medical advice.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Peptide Uses: Medicine, Skincare, Wellness, and More – GoodRx

  • Expert Spotlight: Exploring Peptide Therapy’s Potential in Women’s Reproductive Health

    Expert Spotlight: Exploring Peptide Therapy’s Potential in Women’s Reproductive Health

    Peptide therapy continues to expand its footprint across specialty medicine, and women’s reproductive health is emerging as a promising area of interest. In a recent feature with Contemporary OB/GYN, Dr. Carrie Carda shared her clinical perspective on how peptide-based approaches are being explored for conditions such as polycystic ovary syndrome (PCOS), endometriosis, and fertility support.

    As a physician actively working in this space, Dr. Carda’s insights reflect a broader trend of medical professionals looking beyond conventional treatment paradigms to consider how targeted peptide compounds might complement existing care strategies. These conditions affect millions of women worldwide and often come with limited treatment options, making any additional avenues for symptom management or support particularly meaningful to both patients and practitioners.

    The discussion underscores an encouraging shift within the medical community: peptides are increasingly being taken seriously as a legitimate area of clinical exploration rather than a niche or fringe interest. When specialists in fields like obstetrics and gynecology begin publicly discussing peptide applications, it signals growing confidence in the science and a willingness to integrate emerging therapies into thoughtful, patient-centered care models.

    For women navigating the challenges of PCOS, endometriosis, or fertility concerns, having physicians who are knowledgeable about a wider range of therapeutic options can be empowering. It reflects a healthcare landscape that is evolving to meet patients where they are, with providers staying curious and informed about new developments that could potentially enhance quality of life and reproductive wellness.

    As research and clinical experience with peptides in women’s health continue to grow, conversations like this one help pave the way for more informed patient-provider discussions and, potentially, more personalized care pathways in the future. This article is for informational purposes only and is not intended as medical advice.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: Carrie Carda, MD, on peptide therapy for PMOS, endometriosis, and fertility – Contemporary OB/GYN

  • Understanding Peptides: How GLP-1s and Insulin Are Helping Patients Today

    Peptides have quietly become one of the most impactful tools in modern medicine, and a recent explainer from NewYork-Presbyterian is helping patients understand just how far-reaching their benefits already are. From the now-familiar GLP-1 medications used to manage blood sugar and weight, to insulin—arguably the most successful peptide therapy in history—these small but powerful molecules are woven into everyday healthcare in ways many people don’t realize.

    The article highlights how peptides work by mimicking or supporting natural hormones and signaling molecules in the body. Insulin, discovered over a century ago, remains a life-saving example of how a naturally occurring peptide can be replicated and delivered as medicine to help people with diabetes manage their condition safely and effectively. Building on that legacy, newer GLP-1 receptor agonists have expanded what’s possible, offering additional options for blood sugar control and weight management that have benefited a growing number of patients.

    What’s encouraging about this kind of coverage is the emphasis on education and accessibility. As peptide therapies become more mainstream, patients are increasingly seeking clear, trustworthy information about how these treatments work, what conditions they can help with, and how they fit into broader care plans. Institutions like NewYork-Presbyterian stepping in to provide accurate, digestible explanations helps demystify a class of medicine that can otherwise seem complex or intimidating.

    This growing public understanding also reflects the broader momentum behind peptide research. As scientists continue to explore new peptide-based approaches for metabolic health, hormone regulation, and beyond, patient education becomes an essential part of ensuring these advances are used safely and effectively. Clear guidance from trusted medical institutions can empower patients to have more informed conversations with their healthcare providers about whether peptide-based treatments might be right for them.

    As the peptide field continues to expand, resources like this serve as a reminder that some of the most transformative medical tools are also among the most well-established—and that ongoing innovation is building on a strong foundation of proven benefit. This article is for informational purposes only and is not medical advice.


    Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.

    Source: From GLP-1s to Insulin: What to Know About Peptides – NewYork-Presbyterian